| BSE: 526075 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE092O01028 |
| BSE 00:00 | 02 Jul | Rekvina Labs Ltd is not traded on BSE in the last 30 days |
| NSE 05:30 | 01 Jan | Rekvina Labs Ltd Not listed in NSE |
| OPEN | 5.21 |
| PREVIOUS CLOSE | 5.21 |
| VOLUME | 10 |
| 52-Week high | 5.52 |
| 52-Week low | 5.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
| Parameter | Values | ||
| Market Cap | ( cr) |
3 | |
| EPS - TTM | () |
[*S] | - |
| P/E Ratio | (X) | [*S] | - |
| Face Value | () |
5 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 0.67 |
| P/B Ratio | () |
[*S] | 7.78 |
Board Meeting Intimation for To Consider And Take On Record The Unaudited Financial Results Of The C
Statement Of Investor Complaints For The Quarter Ended June 2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Outcome Of The Board Meeting Held Today And Financial Results For March 31 2018
Particulars ( cr) |
Jun 2018 | Jun 2017 | % Chg |
| Net Sales | - | ||
| Other Income | - | ||
| Total Income | - | ||
| Total Expenses | 0.03 | 0.02 | 50 |
| Operating Profit | -0.03 | -0.02 | -50 |
| Net Profit | -0.03 | -0.02 | -50 |
| Equity Capital | 3.01 | 3.01 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Shukra Pharma. | 74.05 | -4.94 | 11.63 |
| Advik Labs. | 4.01 | 0.00 | 7.66 |
| Zenith Health | 1.42 | 4.41 | 7.63 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | NA | NA | -0.60% | -0.46% |
| 1 Month | NA | NA | 4.05% | 4.39% |
| 3 Month | NA | NA | 6.81% | 6.30% |
| 6 Month | NA | NA | 11.13% | 9.23% |
| 1 Year | NA | NA | 18.97% | 15.36% |
| 3 Year | -45.56% | NA | 34.66% | 34.03% |
| Today's Low/High | 5.21 |
|
5.21 |
| Week Low/High | 0.00 |
|
5.21 |
| Month Low/High | 0.00 |
|
5.21 |
| YEAR Low/High | 5.00 |
|
6.00 |
| All TIME Low/High | 0.50 |
|
78.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
